Landscape Capital Management L.L.C. Purchases Shares of 5,599 Encompass Health Corporation $EHC

Key Points

• Landscape Capital Management L.L.C. has invested approximately $567,000 in Encompass Health Corporation by acquiring 5,599 shares during the first quarter.
• Encompass Health recently announced a quarterly dividend increase to $0.19, reflecting an annualized dividend yield of 0.6%.
• The company's stock price opened at $121.71, experiencing a slight decrease of 1.4%, with a current market cap of $12.26 billion.

Landscape Capital Management L.L.C. purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 5,599 shares of the company's stock, valued at approximately $567,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd raised its stake in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock worth $73,000 after acquiring an additional 115 shares during the period. Arlington Trust Co LLC lifted its holdings in shares of Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares in the last quarter. IFP Advisors Inc lifted its holdings in shares of Encompass Health by 5.9% in the first quarter. IFP Advisors Inc now owns 2,814 shares of the company's stock worth $285,000 after buying an additional 158 shares in the last quarter. Merit Financial Group LLC lifted its holdings in shares of Encompass Health by 4.1% in the first quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock worth $427,000 after buying an additional 166 shares in the last quarter. Finally, Sequoia Financial Advisors LLC lifted its holdings in shares of Encompass Health by 6.7% in the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after buying an additional 172 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares of the company's stock, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. KeyCorp boosted their target price on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Truist Financial boosted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. Finally, UBS Group boosted their price target on shares of Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $134.00.

Encompass Health Trading Up 0.7%

EHC stock traded up $0.85 during mid-day trading on Thursday, reaching $124.48. 245,979 shares of the stock traded hands, compared to its average volume of 809,303. The stock has a market capitalization of $12.54 billion, a PE ratio of 24.33, a PEG ratio of 2.13 and a beta of 0.92. Encompass Health Corporation has a one year low of $87.85 and a one year high of $124.68. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The business has a 50-day moving average price of $116.80 and a two-hundred day moving average price of $111.54.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the previous year, the firm earned $1.11 earnings per share. The business's revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is currently 14.87%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.